DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleDSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsAndrew Brenner